Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives
Molecules · 2025
DOI: 10.3390/molecules30163400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Lina Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng Universit…. Hauptthemen laut MEDLINE: Anticonvulsants, Drug Design, Triazoles, Amides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong, “Guangyue Young Scholar Innovation Team” of Liaocheng University.
Abstract (Originalsprache)
To discover novel, potent anticonvulsant compounds, a series of compounds containing triazole structural fragments were synthesized and evaluated for their anticonvulsant activity. Compounds 6f (maximal electroshock (MES), 50% effective dose (ED50) = 13.1 mg/kg; subcutaneous pentylenetetrazole (scPTZ), ED50 = 19.7 mg/kg) and 6l (MES, ED50 = 9.1 mg/kg; scPTZ, ED50 = 19.0 mg/kg) showed the best activity in MES and scPTZ tests. The results of an affinity test showed that the potent compounds had better binding to the GABAA receptors. The results of an inhibitory neurotransmitter GABA content test in brain tissue indicated that compounds 6f and 6l exerted anticonvulsant activity which may be associated with the increase of GABA content in the rat brain. Elevated plus maze (EPM) assay results showed that compounds 6f and 6l possessed anxiolytic effects, and their effects correlated with the binding sites of benzodiazepines (BZs) in the GABAA receptors. Molecular docking was performed to investigate the interactions of the studied compound 6l with the GABAA receptors on the molecular level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Macromolecular Drugs and Large-Scale Preparation, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252059, China.
- School of Medicine, Foshan University, Foshan 528000, China.
ORCID-Profile: Hui Yan, Shiben Wang
Förderung
- Natural Science Foundation of Shandong
- “Guangyue Young Scholar Innovation Team” of Liaocheng University
Zitieren
APA
Hu, L., Li, M., Liu, Z., Yan, H., Wang, X., & Wang, S. (2025). Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives. Molecules. https://doi.org/10.3390/molecules30163400
Vancouver
Hu L, Li M, Liu Z, Yan H, Wang X, Wang S. Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives. Molecules. 2025. doi:10.3390/molecules30163400
BibTeX
@article{Hu2025,
author = {Hu, Lina and Li, Mengjiao and Liu, Zheng and Yan, Hui and Wang, Xuekun and Wang, Shiben},
title = {Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30163400}
}
EUVIMED